BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zenith L, Meena N, Ramadi A, Yavari M, Harvey A, Carbonneau M, Ma M, Abraldes JG, Paterson I, Haykowsky MJ, Tandon P. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol 2014; 12: 1920-6. e2. [PMID: 24768811 DOI: 10.1016/j.cgh.2014.04.016] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Allampati S, Mullen KD. Long-Term Management of Alcoholic Liver Disease. Clinics in Liver Disease 2016;20:551-62. [DOI: 10.1016/j.cld.2016.02.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
2 Ney M, Gramlich L, Mathiesen V, Bailey RJ, Haykowsky M, Ma M, Abraldes JG, Tandon P. Patient-perceived barriers to lifestyle interventions in cirrhosis. Saudi J Gastroenterol 2017;23:97-104. [PMID: 28361840 DOI: 10.4103/1319-3767.203357] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
3 Vuille-lessard É, Lange N, Riebensahm C, Dufour J, Berzigotti A. Dietary Interventions in Liver Diseases: Focus on MAFLD and Cirrhosis. Curr Hepatology Rep 2021;20:61-76. [DOI: 10.1007/s11901-021-00563-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Williams FR, Berzigotti A, Lord JM, Lai JC, Armstrong MJ. Review article: impact of exercise on physical frailty in patients with chronic liver disease. Aliment Pharmacol Ther 2019;50:988-1000. [PMID: 31502264 DOI: 10.1111/apt.15491] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
5 Faccioli J, Nardelli S, Gioia S, Riggio O, Ridola L. Nutrition Assessment and Management in Patients with Cirrhosis and Cognitive Impairment: A Comprehensive Review of Literature. J Clin Med 2022;11:2842. [PMID: 35628968 DOI: 10.3390/jcm11102842] [Reference Citation Analysis]
6 Garcia LA, Zapata-bustos R, Day SE, Campos B, Hamzaoui Y, Wu L, Leon AD, Krentzel J, Coletta RL, De Filippis E, Roust LR, Mandarino LJ, Coletta DK. Can Exercise Training Alter Human Skeletal Muscle DNA Methylation? Metabolites 2022;12:222. [DOI: 10.3390/metabo12030222] [Reference Citation Analysis]
7 Ney M, Tangri N, Dobbs B, Bajaj J, Rolfson D, Ma M, Ferguson T, Bhardwaj P, Bailey RJ, Abraldes J, Tandon P. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis. Am J Gastroenterol 2018;113:1506-15. [PMID: 30267028 DOI: 10.1038/s41395-018-0243-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
8 Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology 2019;70:1816-29. [PMID: 31220351 DOI: 10.1002/hep.30828] [Cited by in Crossref: 108] [Cited by in F6Publishing: 92] [Article Influence: 36.0] [Reference Citation Analysis]
9 Ohashi K, Ishikawa T, Hoshi A, Suzuki M, Mitobe Y, Yamada E, Abeywickrama HM, Seki N, Koyama C, Aoki H, Koyama Y. Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease. J Clin Med Res 2018;10:920-7. [PMID: 30425765 DOI: 10.14740/jocmr3640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
10 Nascimento ESP, Nunes WMC, Guerra EM, da Roza MR, Silva-Costa S, Machado-Silva W, Avelar GG, de Toledo Nóbrega O, Vieira RP, Amado VM, Melo-Silva CA. Combined exercise training improved exercise capacity and lung inflammation in rats with hepatopulmonary syndrome. Life Sci 2021;287:120112. [PMID: 34728228 DOI: 10.1016/j.lfs.2021.120112] [Reference Citation Analysis]
11 Morkane CM, Kearney O, Bruce DA, Melikian CN, Martin DS. An Outpatient Hospital-based Exercise Training Program for Patients With Cirrhotic Liver Disease Awaiting Transplantation: A Feasibility Trial. Transplantation 2020;104:97-103. [DOI: 10.1097/tp.0000000000002803] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 7.5] [Reference Citation Analysis]
12 Walcott-Sapp S, Billingsley KG. Preoperative optimization for major hepatic resection. Langenbecks Arch Surg 2018;403:23-35. [PMID: 29150719 DOI: 10.1007/s00423-017-1638-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
13 Sinclair M. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice. Nutrients. 2019;11:2454. [PMID: 31615103 DOI: 10.3390/nu11102454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
14 Al-judaibi B, Alqalami I, Sey M, Qumosani K, Howes N, Sinclair L, Chandok N, Eddin AH, Hernandez-alejandro R, Marotta P, Teriaky A. Exercise Training for Liver Transplant Candidates. Transplantation Proceedings 2019;51:3330-7. [DOI: 10.1016/j.transproceed.2019.08.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
15 Merli M, Iebba V, Giusto M. What is new about diet in hepatic encephalopathy. Metab Brain Dis. 2016;31:1289-1294. [PMID: 26419384 DOI: 10.1007/s11011-015-9734-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
16 Freer A, Williams F, Durman S, Hayden J, Trivedi PJ, Armstrong MJ. Home-based exercise in patients with refractory fatigue associated with primary biliary cholangitis: a protocol for the EXerCise Intervention in cholesTatic LivEr Disease (EXCITED) feasibility trial. BMJ Open Gastroenterol 2021;8:e000579. [PMID: 33707216 DOI: 10.1136/bmjgast-2020-000579] [Reference Citation Analysis]
17 Pugliese N, Arcari I, Aghemo A, Lania AG, Lleo A, Mazziotti G. Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges . World J Gastroenterol 2022; 28(14): 1430-1443 [DOI: 10.3748/wjg.v28.i14.1430] [Reference Citation Analysis]
18 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Reference Citation Analysis]
19 Nishikawa H, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Sarcopenia and Frailty in Liver Cirrhosis. Life (Basel) 2021;11:399. [PMID: 33925660 DOI: 10.3390/life11050399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Koya S, Kawaguchi T, Hashida R, Goto E, Matsuse H, Saito H, Hirota K, Taira R, Matsushita Y, Imanaga M, Nagamatsu A, Shirono T, Shimose S, Iwamoto H, Niizeki T, Kuromatsu R, Miura H, Shiba N, Torimura T. Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease. Hepatol Res 2017;47:E22-34. [PMID: 27062043 DOI: 10.1111/hepr.12718] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
21 Moctezuma-Velázquez C, Low G, Mourtzakis M, Ma M, Burak KW, Tandon P, Montano-Loza AJ. Association between Low Testosterone Levels and Sarcopenia in Cirrhosis: A Cross-sectional Study. Ann Hepatol 2018;17:615-23. [PMID: 29893704 DOI: 10.5604/01.3001.0012.0930] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
22 Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 2020;51:64-77. [PMID: 31701570 DOI: 10.1111/apt.15571] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
23 Essam Behiry M, Mogawer S, Yamany A, Rakha M, Awad R, Emad N, Abdelfatah Y. Ability of the Short Physical Performance Battery Frailty Index to Predict Mortality and Hospital Readmission in Patients with Liver Cirrhosis. Int J Hepatol 2019;2019:8092865. [PMID: 31186966 DOI: 10.1155/2019/8092865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Sato Y, Qiu J, Miura T, Kohzuki M, Ito O. Effects of Long-Term Exercise on Liver Cyst in Polycystic Liver Disease Model Rats. Med Sci Sports Exerc 2020;52:1272-9. [PMID: 31880641 DOI: 10.1249/MSS.0000000000002251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
25 Macías-Rodríguez RU, Ilarraza-Lomelí H, Ruiz-Margáin A, Ponce-de-León-Rosales S, Vargas-Vorácková F, García-Flores O, Torre A, Duarte-Rojo A. Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical Trial. Clin Transl Gastroenterol 2016;7:e180. [PMID: 27415618 DOI: 10.1038/ctg.2016.38] [Cited by in F6Publishing: 57] [Reference Citation Analysis]
26 Ney M, Haykowsky MJ, Vandermeer B, Shah A, Ow M, Tandon P. Systematic review: pre- and post-operative prognostic value of cardiopulmonary exercise testing in liver transplant candidates. Aliment Pharmacol Ther. 2016;44:796-806. [PMID: 27539029 DOI: 10.1111/apt.13771] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
27 Mazurak VC, Tandon P, Montano-loza AJ. Nutrition and the transplant candidate: Mazurak et al. Liver Transpl 2017;23:1451-64. [DOI: 10.1002/lt.24848] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
28 Kok B, McNeely M, Watt M, Tandon P. Exercise Only Works If You Do It! The Holy Grail of Adherence. Am J Gastroenterol 2021;116:673-4. [PMID: 33982935 DOI: 10.14309/ajg.0000000000001198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Dhaliwal A, Towey J, Lord JM, Armstrong M, Elsharkawy AM. Nutrition in liver cirrhosis: a case-based overview. Frontline Gastroenterol 2020;11:155-61. [PMID: 32133115 DOI: 10.1136/flgastro-2018-101121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
30 Brustia R, Savier E, Scatton O. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2018;42:205-15. [PMID: 29162460 DOI: 10.1016/j.clinre.2017.09.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
31 Aamann L, Ochoa-Sanchez R, Oliveira M, Tremblay M, Bémeur C, Dam G, Vilstrup H, Aagaard NK, Rose CF. Progressive resistance training prevents loss of muscle mass and strength in bile duct-ligated rats. Liver Int 2019;39:676-83. [PMID: 30394651 DOI: 10.1111/liv.13997] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Aamann L, Tandon P, Bémeur C. Role of Exercise in the Management of Hepatic Encephalopathy: Experience From Animal and Human Studies. J Clin Exp Hepatol 2019;9:131-6. [PMID: 30765946 DOI: 10.1016/j.jceh.2018.07.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Nasser I, Miranda H, Perez RM, Cabiddu R, Malosa L, Dias I, Brown A, Reis MS. Limited cardiopulmonary capacity in patients with liver cirrhosis when compared to healthy subjects. Rev Assoc Med Bras (1992) 2021;67:94-100. [PMID: 34161483 DOI: 10.1590/1806-9282.67.01.20200449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Trivedi HD, Tapper EB. Interventions to improve physical function and prevent adverse events in cirrhosis. Gastroenterol Rep (Oxf) 2018;6:13-20. [PMID: 29479438 DOI: 10.1093/gastro/gox042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
35 Saiman Y, Serper M. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant. Clin Liver Dis 2021;25:35-51. [PMID: 33978582 DOI: 10.1016/j.cld.2020.08.004] [Reference Citation Analysis]
36 Chen HW, Dunn MA. Arresting frailty and sarcopenia in cirrhosis: Future prospects. Clin Liver Dis (Hoboken) 2018;11:52-7. [PMID: 30992788 DOI: 10.1002/cld.691] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Neuberger J, Armstrong MJ, Fisher J, Mark P, Schmidtke K, Sharif A, Vlaev I. Sport and Exercise in Improving Outcomes After Solid Organ Transplantation: Overview From a UK Meeting. Transplantation. 2019;103:S1-S11. [PMID: 31259878 DOI: 10.1097/tp.0000000000002710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
38 Perisetti A, Goyal H, Yendala R, Chandan S, Tharian B, Thandassery RB. Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions. World J Gastroenterol 2022; 28(4): 432-448 [DOI: 10.3748/wjg.v28.i4.432] [Reference Citation Analysis]
39 Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, Dajti E, Ravaioli F, Golfieri R, Cescon M, Festi D, Colecchia A. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol 2020;55:927-43. [PMID: 32748172 DOI: 10.1007/s00535-020-01711-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
40 Brustia R, Scatton O. Pretransplant sarcopenia: suffer or fight? Hepatobiliary Surg Nutr 2017;6:260-3. [PMID: 28848749 DOI: 10.21037/hbsn.2017.03.15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
41 Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186. [PMID: 31936597 DOI: 10.3390/nu12010186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
42 Paternostro R, Lampichler K, Bardach C, Asenbaum U, Landler C, Bauer D, Mandorfer M, Schwarzer R, Trauner M, Reiberger T, Ferlitsch A. The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis. Liver Int. 2019;39:2374-2385. [PMID: 31421002 DOI: 10.1111/liv.14217] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
43 Aamann L, Dam G, Rinnov AR, Vilstrup H, Gluud LL. Physical exercise for people with cirrhosis. Cochrane Database Syst Rev 2018;12:CD012678. [PMID: 30575956 DOI: 10.1002/14651858.CD012678.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
44 Tandon P, Ismond KP, Riess K, Duarte-rojo A, Al-judaibi B, Dunn MA, Holman J, Howes N, Haykowsky MJF, Josbeno DA, Mcneely M. Exercise in cirrhosis: Translating evidence and experience to practice. Journal of Hepatology 2018;69:1164-77. [DOI: 10.1016/j.jhep.2018.06.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 16.3] [Reference Citation Analysis]
45 Tandon P, Dunn MA, Duarte-Rojo A. Resistance Training Reduces Risk of Sarcopenia in Patients With Cirrhosis. Clin Gastroenterol Hepatol 2020;18:1036-9. [PMID: 31589977 DOI: 10.1016/j.cgh.2019.09.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Bezinover D, Geyer NR, Dahmus J, Chinchilli VM, Stine JG. A decline in functional status while awaiting liver transplantation is predictive of increased post-transplantation mortality. HPB (Oxford) 2021:S1365-182X(21)01664-6. [PMID: 34772623 DOI: 10.1016/j.hpb.2021.10.008] [Reference Citation Analysis]
47 West J, Gow PJ, Testro A, Chapman B, Sinclair M. Exercise physiology in cirrhosis and the potential benefits of exercise interventions: A review. J Gastroenterol Hepatol 2021. [PMID: 33638197 DOI: 10.1111/jgh.15474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Locklear CT, Golabi P, Gerber L, Younossi ZM. Exercise as an intervention for patients with end-stage liver disease: Systematic review. Medicine (Baltimore). 2018;97:e12774. [PMID: 30334965 DOI: 10.1097/md.0000000000012774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
49 Puchades Renau L, Herreras López J, Cebrià I Iranzo MÀ, Cezón Serrano N, Di Maira T, Berenguer M. Frailty and Sarcopenia in Acute-on-Chronic Liver Failure. Hepatol Commun 2021;5:1333-47. [PMID: 34430779 DOI: 10.1002/hep4.1722] [Reference Citation Analysis]
50 Tsochatzis E, Coilly A, Nadalin S, Levistky J, Tokat Y, Ghobrial M, Klinck J, Berenguer M. International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation. Transplantation. 2019;103:45-56. [PMID: 30153225 DOI: 10.1097/tp.0000000000002433] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 10.3] [Reference Citation Analysis]
51 McCabe P, Gish RG, Cheung R, Wong RJ. More Severe Deficits in Performance Status at Time of Liver Transplant is Associated With Significantly Higher Risk of Death Following Liver Transplantation. J Clin Gastroenterol 2019;53:e392-9. [PMID: 30762610 DOI: 10.1097/MCG.0000000000001187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
52 Thandassery RB, Montano-Loza AJ. Role of Nutrition and Muscle in Cirrhosis. Curr Treat Options Gastroenterol. 2016;14:257-273. [PMID: 27023701 DOI: 10.1007/s11938-016-0093-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
53 Dasarathy S. Cause and management of muscle wasting in chronic liver disease. Curr Opin Gastroenterol. 2016;32:159-165. [PMID: 26974417 DOI: 10.1097/mog.0000000000000261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
54 Schmilovitz-Weiss H, Boltin D, Groshar D, Domachevsky L, Rosenbaum E, Issa N, Sapoznikov B, Goren I, Issachar A, Cohen-Naftaly M, Weiss A, Gingold-Belfer R, Bernstine H. [¹¹C] choline as a potential PET/CT biomarker of liver cirrhosis: A prospective pilot study. Dig Liver Dis 2021;53:753-9. [PMID: 33272861 DOI: 10.1016/j.dld.2020.11.013] [Reference Citation Analysis]
55 de Mello CL, da Conceição TMA, Dal Pont T, Peruzzolo CC, Lúcio MN, Paulin E. The Benefits of Neuromuscular Electrical Stimulation in the Muscular and Functional Capacity of Patients With Liver Cirrhosis: Protocol for a Randomized Clinical Trial. Clin Med Insights Gastroenterol 2018;11:1179552218811834. [PMID: 30505152 DOI: 10.1177/1179552218811834] [Reference Citation Analysis]
56 Dunn MA. The cost of sarcopenia. Transpl Int 2018;31:155-6. [DOI: 10.1111/tri.13069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
57 Paternostro R, Bardach C, Hofer BS, Scheiner B, Schwabl P, Asenbaum U, Ba-Ssalamah A, Scharitzer M, Bucscis T, Simbrunner B, Bauer D, Trauner M, Mandorfer M, Reiberger T, Lampichler K. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int. 2021;41:799-809. [PMID: 33290614 DOI: 10.1111/liv.14758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Koretz RL. JPEN Journal Club 53. The Narrative Review. JPEN J Parenter Enteral Nutr 2020;44:1355-7. [PMID: 32227597 DOI: 10.1002/jpen.1832] [Reference Citation Analysis]
59 Aamann L, Dam G, Borre M, Drljevic-Nielsen A, Overgaard K, Andersen H, Vilstrup H, Aagaard NK. Resistance Training Increases Muscle Strength and Muscle Size in Patients With Liver Cirrhosis. Clin Gastroenterol Hepatol 2020;18:1179-1187.e6. [PMID: 31394282 DOI: 10.1016/j.cgh.2019.07.058] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
60 Kruger C, McNeely ML, Bailey RJ, Yavari M, Abraldes JG, Carbonneau M, Newnham K, DenHeyer V, Ma M, Thompson R, Paterson I, Haykowsky MJ, Tandon P. Home Exercise Training Improves Exercise Capacity in Cirrhosis Patients: Role of Exercise Adherence. Sci Rep. 2018;8:99. [PMID: 29311671 DOI: 10.1038/s41598-017-18320-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
61 Williams FR, Vallance A, Faulkner T, Towey J, Durman S, Kyte D, Elsharkawy AM, Perera T, Holt A, Ferguson J, Lord JM, Armstrong MJ. Home‐Based Exercise in Patients Awaiting Liver Transplantation: A Feasibility Study. Liver Transpl 2019;25:995-1006. [DOI: 10.1002/lt.25442] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
62 Rogal SS, Hansen L, Patel A, Ufere NN, Verma M, Woodrell CD, Kanwal F. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022. [PMID: 35103995 DOI: 10.1002/hep.32378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
63 Mochamat, Cuhls H, Sellin J, Conrad R, Radbruch L, Mücke M. Fatigue in advanced disease associated with palliative care: A systematic review of non-pharmacological treatments. Palliat Med 2021;35:697-709. [PMID: 33765888 DOI: 10.1177/02692163211000628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Dhaliwal A, Williams FR, El-sherif O, Armstrong MJ. Sarcopenia in Liver Transplantation: an Update. Curr Hepatology Rep 2020;19:128-37. [DOI: 10.1007/s11901-020-00515-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Mikkelsen MR, Hendriksen C, Schiødt FV, Rydahl-hansen S. Alcoholic liver disease patients’ perspective of a coping and physical activity-oriented rehabilitation intervention after hepatic encephalopathy. J Clin Nurs 2016;25:2457-67. [DOI: 10.1111/jocn.13265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
67 Schneider CV, Zandvakili I, Thaiss CA, Schneider KM. Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. JHEP Rep 2021;3:100263. [PMID: 33898961 DOI: 10.1016/j.jhepr.2021.100263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 18.3] [Reference Citation Analysis]
69 Londoño MC, Abraldes JG, Altamirano J, Deacens T, Forns X. Clinical trial watch: reports from the Liver Meeting (American Association for the Study of Liver Diseases), Boston, November 2014. J Hepatol. 2015; Jan 31. [Epub ahead of print]. [PMID: 25646885 DOI: 10.1016/j.jhep.2015.01.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
70 Moctezuma-Velazquez C, Márquez-Guillén E, Torre A. Obesity in the Liver Transplant Setting. Nutrients 2019;11:E2552. [PMID: 31652761 DOI: 10.3390/nu11112552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
71 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 39.0] [Reference Citation Analysis]
72 Dunn MA, Josbeno DA, Schmotzer AR, Tevar AD, DiMartini AF, Landsittel DP, Delitto A. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl 2016;22:1324-32. [PMID: 27348200 DOI: 10.1002/lt.24506] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
73 Montgomery J, Englesbe M. Sarcopenia in Liver Transplantation. Curr Transplant Rep 2019;6:7-15. [PMID: 31595213 DOI: 10.1007/s40472-019-0223-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Bellar A, Welch N, Dasarathy S. Exercise and physical activity in cirrhosis: opportunities or perils. J Appl Physiol (1985) 2020;128:1547-67. [PMID: 32240017 DOI: 10.1152/japplphysiol.00798.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Naseer M, Turse EP, Syed A, Dailey FE, Zatreh M, Tahan V. Interventions to improve sarcopenia in cirrhosis: A systematic review. World J Clin Cases 2019; 7(2): 156-170 [PMID: 30705893 DOI: 10.12998/wjcc.v7.i2.156] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
76 Lai JC, Dodge JL, Kappus MR, Wong R, Mohamad Y, Segev DL, McAdams-DeMarco M. A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE). Am J Gastroenterol 2021;116:717-22. [PMID: 33982941 DOI: 10.14309/ajg.0000000000001113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
77 Berzigotti A, Saran U, Dufour JF. Physical activity and liver diseases. Hepatology 2016;63:1026-40. [PMID: 26313307 DOI: 10.1002/hep.28132] [Cited by in Crossref: 103] [Cited by in F6Publishing: 83] [Article Influence: 17.2] [Reference Citation Analysis]
78 Macías-Rodríguez RU, Ruiz-Margáin A, Román-Calleja BM, Espin-Nasser ME, Flores-García NC, Torre A, Galicia-Hernández G, Rios-Torres SL, Fernández-del-Rivero G, Orea-Tejeda A, Lozano-Cruz OA. Effect of non-alcoholic beer, diet and exercise on endothelial function, nutrition and quality of life in patients with cirrhosis. World J Hepatol 2020; 12(12): 1299-1313 [PMID: 33442456 DOI: 10.4254/wjh.v12.i12.1299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Takeda S, Kaji K, Nishimura N, Enomoto M, Fujimoto Y, Murata K, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H. Angiotensin Receptor Blockers Potentiate the Protective Effect of Branched-Chain Amino Acids on Skeletal Muscle Atrophy in Cirrhotic Rats. Mol Nutr Food Res 2021;65:e2100526. [PMID: 34687151 DOI: 10.1002/mnfr.202100526] [Reference Citation Analysis]
80 Dunn MA, Kappus MR, Bloomer PM, Duarte-Rojo A, Josbeno DA, Jakicic JM. Wearables, Physical Activity, and Exercise Testing in Liver Disease. Semin Liver Dis 2021;41:128-35. [PMID: 33788206 DOI: 10.1055/s-0040-1716564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Yamaguchi T, Makiguchi T, Nakamura H, Yamatsu Y, Hirai Y, Shoda K, Suzuki K, Kim M, Kurozumi S, Motegi SI, Shirabe K, Yokoo S. Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection. Int J Oral Maxillofac Surg 2021;50:1195-202. [PMID: 33414037 DOI: 10.1016/j.ijom.2020.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Fox R, Stenning K, Slee A, Macnaughtan J, Davies N. Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies. Analytical Biochemistry 2022. [DOI: 10.1016/j.ab.2022.114581] [Reference Citation Analysis]
83 . Ueg Week 2020 Poster Presentations. United European Gastroenterol j 2020;8:144-887. [DOI: 10.1177/2050640620927345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
84 McCabe P, Wong RJ. More severe deficits in functional status associated with higher mortality among adults awaiting liver transplantation. Clin Transplant 2018;32:e13346. [PMID: 29979466 DOI: 10.1111/ctr.13346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
85 Sirisunhirun P, Bandidniyamanon W, Jrerattakon Y, Muangsomboon K, Pramyothin P, Nimanong S, Tanwandee T, Charatcharoenwitthaya P, Chainuvati S, Chotiyaputta W. Effect of a 12-week home-based exercise training program on aerobic capacity, muscle mass, liver and spleen stiffness, and quality of life in cirrhotic patients: a randomized controlled clinical trial. BMC Gastroenterol 2022;22:66. [PMID: 35164698 DOI: 10.1186/s12876-022-02147-7] [Reference Citation Analysis]
86 Abdelbasset WK, Nambi G, Elsayed SH, Moawd SA, Ibrahim AA, Verma A, Tantawy SA, Kamel DM, Saleh AK, Aldhafian OR, Nwihadh NB. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients. Dis Markers 2021;2021:8866093. [PMID: 33628339 DOI: 10.1155/2021/8866093] [Reference Citation Analysis]
87 Zelber-Sagi S, Ivancovsky-Wajcman D, Rabinowich L, Bentov I, Deutsch L. Nutritional Evaluation and Treatment of the Cirrhotic Patient. Clin Liver Dis 2021;25:373-92. [PMID: 33838856 DOI: 10.1016/j.cld.2021.01.007] [Reference Citation Analysis]
88 Burra P, Giannini EG, Caraceni P, Ginanni Corradini S, Rendina M, Volpes R, Toniutto P. Specific issues concerning the management of patients on the waiting list and after liver transplantation. Liver Int 2018;38:1338-62. [PMID: 29637743 DOI: 10.1111/liv.13755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
89 Ravikiran SK, Bhat M. Editorial: effect of exercise on physical frailty in patients with chronic liver disease. Aliment Pharmacol Ther 2019;50:1241-2. [PMID: 31709608 DOI: 10.1111/apt.15534] [Reference Citation Analysis]
90 Bot D, Droop A, Lucassen CJ, van Veen ME, van Vugt JLA, Shahbazi Feshtali S, Leistra E, Tushuizen ME, van Hoek B. Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease. Clin Nutr ESPEN 2021;42:272-9. [PMID: 33745592 DOI: 10.1016/j.clnesp.2021.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Román E, García-Galcerán C, Torrades T, Herrera S, Marín A, Doñate M, Alvarado-Tapias E, Malouf J, Nácher L, Serra-Grima R, Guarner C, Cordoba J, Soriano G. Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial. PLoS One 2016;11:e0151652. [PMID: 27011355 DOI: 10.1371/journal.pone.0151652] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 11.5] [Reference Citation Analysis]
92 Nóbrega SR, Chachá SGF, Libardi CA. Resistance training combined with blood flow restriction in cirrhosis: study protocol for a randomized controlled trial. Trials 2020;21:446. [PMID: 32471480 DOI: 10.1186/s13063-020-04410-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70:172-193. [PMID: 30144956 DOI: 10.1016/j.jhep.2018.06.024] [Cited by in Crossref: 207] [Cited by in F6Publishing: 160] [Article Influence: 51.8] [Reference Citation Analysis]
94 Nasser I, Perez RM, Reis MS, Dias I, Willardson JM, Miranda H. Cardiovascular Acute Effects of Traditional vs. Paired Set Resistance Training in Patients With Liver Cirrhosis. Res Q Exerc Sport 2020;91:630-9. [PMID: 31999503 DOI: 10.1080/02701367.2019.1696013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Grancini V, Resi V, Palmieri E, Pugliese G, Orsi E. Management of diabetes mellitus in patients undergoing liver transplantation. Pharmacol Res. 2019;141:556-573. [PMID: 30690071 DOI: 10.1016/j.phrs.2019.01.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
96 Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, Burak KW, Bailey RJ, Lai JC, Tandon P. Frailty is associated with increased risk of cirrhosis disease progression and death. Hepatology 2022;75:600-9. [PMID: 34528267 DOI: 10.1002/hep.32157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
97 Tapper EB, Martinez-macias R, Duarte-rojo A. Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension? Curr Hepatology Rep 2018;17:175-83. [DOI: 10.1007/s11901-018-0404-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Sciarrone SS, Zanetto A, Russo FP, Germani G, Gambato M, Battistella S, Pellone M, Shalaby S, Burra P, Senzolo M. Malnourished cirrhotic patient: what should we do? Minerva Gastroenterol (Torino) 2021;67:11-22. [PMID: 33784807 DOI: 10.23736/S2724-5985.20.02776-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Nardelli S, Gioia S, Faccioli J, Riggio O, Ridola L. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy. World J Gastroenterol 2019; 25(35): 5257-5265 [PMID: 31558871 DOI: 10.3748/wjg.v25.i35.5257] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
100 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact. Int J Mol Sci 2021;22:1917. [PMID: 33671926 DOI: 10.3390/ijms22041917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Lin FP, Visina JM, Bloomer PM, Dunn MA, Josbeno DA, Zhang X, Clemente-Sanchez A, Tevar AD, Hughes CB, Jakicic JM, Duarte-Rojo A. Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease. Am J Gastroenterol 2021. [PMID: 34313620 DOI: 10.14309/ajg.0000000000001376] [Reference Citation Analysis]
102 Macías-Rodríguez RU, Ruiz-Margáin A, Román-Calleja BM, Moreno-Tavarez E, Weber-Sangri L, González-Arellano MF, Fernández-Del-Rivero G, Ramírez-Soto K. Exercise prescription in patients with cirrhosis: Recommendations for clinical practice. Rev Gastroenterol Mex (Engl Ed) 2019;84:326-43. [PMID: 31262552 DOI: 10.1016/j.rgmx.2019.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
103 Ohashi K, Ishikawa T, Imai M, Suzuki M, Hoshii A, Abe H, Koyama F, Nakano T, Ueki A, Noguchi H, Hasegawa E, Hirosawa S, Kobayashi M, Hirosawa H, Sato K, Munakata M, Yoshida T. Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study. Eur J Gastroenterol Hepatol 2019;31:1408-13. [PMID: 30964810 DOI: 10.1097/MEG.0000000000001415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
104 Acharya C, Bajaj JS. Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access. Liver Transpl 2021. [PMID: 34018659 DOI: 10.1002/lt.26099] [Reference Citation Analysis]
105 Tandon P, Tangri N, Thomas L, Zenith L, Shaikh T, Carbonneau M, Ma M, Bailey RJ, Jayakumar S, Burak KW, Abraldes JG, Brisebois A, Ferguson T, Majumdar SR. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale. Am J Gastroenterol 2016;111:1759-67. [PMID: 27481305 DOI: 10.1038/ajg.2016.303] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 14.5] [Reference Citation Analysis]
106 Kok B, Tandon P. Frailty in Patients With Cirrhosis. Curr Treat Options Gastroenterol. 2018;16:215-225. [PMID: 29589278 DOI: 10.1007/s11938-018-0179-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
107 Williams FR, Vallance A, Faulkner T, Towey J, Kyte D, Durman S, Johnson J, Holt A, Perera MT, Ferguson J, Armstrong MJ. Home-based exercise therapy in patients awaiting liver transplantation: protocol for an observational feasibility trial. BMJ Open 2018;8:e019298. [PMID: 29358444 DOI: 10.1136/bmjopen-2017-019298] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
108 Rombouts K, Bémeur C, Rose CF. Targeting the muscle for the treatment and prevention of hepatic encephalopathy. Journal of Hepatology 2016;65:876-8. [DOI: 10.1016/j.jhep.2016.08.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
109 Aby ES, Saab S. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients. Clinics in Liver Disease 2019;23:589-605. [DOI: 10.1016/j.cld.2019.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
110 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol 2021;56:593-619. [PMID: 34231046 DOI: 10.1007/s00535-021-01788-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Gonzalez A, Valero-Breton M, Huerta-Salgado C, Achiardi O, Simon F, Cabello-Verrugio C. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Transl Myol 2021;31. [PMID: 33709647 DOI: 10.4081/ejtm.2021.9630] [Reference Citation Analysis]
112 Cigrovski Berkovic M, Bilic-Curcic I, Mrzljak A, Cigrovski V. NAFLD and Physical Exercise: Ready, Steady, Go! Front Nutr 2021;8:734859. [PMID: 34676233 DOI: 10.3389/fnut.2021.734859] [Reference Citation Analysis]